Martin and Harris Laboratories Limited

+30752.99 % 1 M

As of May 11, 2025, Martin and Harris Laboratories Limited share price is INR 850.00 per share and the face value is INR 10.00 per share. The lot size of Martin and Harris Laboratories Limited is 0 shares. The 52 week high for Martin and Harris Laboratories Limited is INR 850.00, while the 52 week low is INR 2.76

About Martin and Harris Laboratories Limited

A Comprehensive Overview of Price & Journey
Understanding Martin and Harris Laboratories Limited Inception and Growth
SHOW MORE...

About Martin and Harris Laboratories Limited

IPO Details, Price movement

Performance Highlights for FY 2023-24

  • Revenue from operation decreased by 29% from INR 205 crore in FY23 to INR 146 crore in FY24. 

  • Total Revenue decreased by 21 % from INR 229.2 crore in FY23 to INR 180.4 crore in FY24.

  • Profit Before Tax decreased by 40% from INR 92.1 crore in FY23 to INR 55.2 crore in FY24. 

  • The Company’s Profit After Tax declined by 41% from INR 68.1 crore in FY23 to INR 40.4 crore in FY24. 

  • Net Cash used in Operating activities was INR 344 crore in FY23 and INR 20 crore in FY24.

  • Cash flow from investing activities was INR 325 crore in FY23 and Net Cash used in investing activities was INR 21 crore in FY24.

  • Net cash used in Financing activities was INR 2 crore in FY23 and INR 1 crore in FY24.

SHOW MORE...

Fundamentals

Market Cap (in cr.)
₹ 3396634000
P/E Ratio
4.72
P/B Ratio
0.53
Debt to Equity
0.00
ROE (%)
28.48
Book Value
1606.57
Face Value
10.00
Total Shares
3996040
Category
Unlisted Shares
Unlisted CMP
₹ 0 / Share
Lot Size
0 Shares
52 Week High
₹850.00
52 Week Low
₹2.76
Depository
NSDL
PAN Number
AABCM0832A
ISIN Number
INE03VV01015
CIN
U24239HR1993PLC033630
Sector
Health Care

Financials

P&L Statement 2021 2022 2023 2024
Revenue - 186.31 205.16 146.15
Other Income - 25.79 24.08 34.29
COGS - 49.96 47.14 41.24
Gross Profit - 162.14 182.10 139.20
Total Expense - 65.12 85.88 78.77
EBIDTA - 97.02 96.23 60.44
D&A - 3.45 3.93 4.63
EBIT - 93.57 92.30 55.80
Interest Expense - 0.16 0.22 0.58
PBT - 93.42 92.08 55.22
TAX - 23.26 24.02 14.79
PAT - 70.16 68.06 40.43
Diluted EPS - 175.57 170.34 101.17
Basic EPS - 175.57 170.34 101.17
Total income 0.00 212.10 229.24 180.44
ASSETS
CURRENT ASSETS 2021 2022 2023 2024
Cash and Cash Equivalents - 21.33 0.82 0.25
Trade Payables - - 1.37 1.97
Inventory - 24.11 18.81 30.46
Other Current Assets - 428.14 512.46 541.95
Total Current Assets 0.00 473.58 533.46 574.63

NON CURRENT ASSETS 2021 2022 2023 2024
Plant Property and Equipment - 13.39 18.94 17.76
Long Term Investment - 55.52 62.18 69.57
Other Non Current Assets - - 0.01 -
TOTOAL NON CURRENT ASSSETS 0.00 68.91 81.13 87.33

Total Assets 0.00 542.49 614.59 661.96

CURRENT LIABILITES 2021 2022 2023 2024
TRADW Payable - 7.28 9.73 16.83
Other Current Liab - 6.74 10.58 12.34
Total Current Liab 0.00 14.02 20.31 29.17

NON CURRENTLIABILITIES 2021 2022 2023 2024
Long Term Debt - - - -
Deffered Tax Liab - 0.15 - 0.13
Other Non Current Liab - 1.07 1.07 0.60

LIABILITIES
EQUITY 2021 2022 2023 2024
Share Capital - 4.00 4.00 4.00
Reserves And Surplus - - - -
Other Equity - 523.33 589.29 628.07
Retained Earnings - - - -
share Equity 0.00 527.33 593.29 632.07

Total Liabilities 0.00 528.55 594.36 632.80

CASH FLOW STAT 2021 2022 2023 2024
Cash Flow from operating - 152.19 -344.02 19.57
Cash Flow from financing - -0.68 -1.94 1.07
Cash Flow from investing - -132.49 325.44 -21.22
Net cash flow 0.00 19.02 -20.52 -0.58

Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Shareholding Pattern
2025
Name Designation Share %
Chang Investchem Private Limited NA 37.53%
Aessen Private Limited NA 20.51%
Acme Network S.A NA 20.07%
Others NA 21.88%
Events
Name Date Details
No events available.
Promoters or Management
Name Designation Linkedin Profile
Shankar Laxman Laad Director
Harnam Thakur Singh Director
Nasim Uddin Director

Frequently Asked Questions

3. What is the lock-in period of Martin and Harris Laboratories Limited/Pre-IPO shares after the shares gets listed?

  • The lockin period is of 6 months for pre-ipo investors i.e. they cannot sell their shares for 6 months after they get listed. However, they can definitely sell the shares in pre-ipo market before they get listed.

4. What is the average ticket size for investing in unlisted shares?
5. How to check credit of Martin and Harris Laboratories Limited/Pre-IPO shares?
6. How is valuation of Martin and Harris Laboratories Limited/Pre-IPO shares is decided?
9. Difference Between Unlisted Company & Listed Company?
10. Short-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
11. Long-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
12. Applicability of Taxes on Unlisted Shares/Pre-IPO shares once it is listed?
13. IS PRE IPO market same as grey market?
14. Who sells private shares?
15. Investing in Martin and Harris Laboratories Limited legal in India?

Related News